Skin Cancer: Diagnosis

Family physicians play a critical role in early detection of skin cancers. Although visual inspection is the initial step, dermoscopy significantly improves diagnostic accuracy, particularly for melanoma and basal cell carcinoma. Advanced imaging technologies such as reflectance confocal microscopy, optical coherence tomography, and high-frequency ultrasonography may further enhance accuracy and reduce unnecessary procedures. However, these technologies are primarily used in academic or specialty dermatology settings. Biopsy is required for definitive diagnosis. For nonmelanoma skin cancers, no single biopsy technique has demonstrated superiority. A shave, punch, incisional, or excisional technique should be selected based on lesion characteristics, patient factors, and clinical judgment. For melanoma, excisional biopsy with margins of 1 to 3 mm and full-thickness removal is preferred. Saucerization (deep shave removal of the entire clinical lesion to the mid-dermis or deeper) may be acceptable if it allows accurate assessment of Breslow depth. Basal cell carcinoma subtypes include nodular, superficial, morpheaform (sclerosing), and infiltrative. Cutaneous squamous cell carcinoma is classified as in situ or invasive. The clinical subtypes of melanoma include superficial spreading, nodular, lentigo maligna melanoma, amelanotic, and acral lentiginous. If biopsy is not feasible because of lesion location or clinical suspicion persists despite benign histology, prompt dermatology referral is warranted.